Evidence map›Paper›PMID 41100167›Full record

ReviewJournal of medicinal chemistry2025

Cheap, Fast, Safe, Sustainable, and Positively Irresistible: The Future of Cationic Amphiphilic Disinfectant Development.

Makayla R Hedges, Kevin P C Minbiole, Barry S Selinsky, William M Wuest

Abstract readReview
In one paragraph

Review in Journal of medicinal chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Makayla R HedgesDepartment of Chemistry, Emory University, Atlanta, Georgia 30322, United States.ORCID 0009-0002-8210-565X
Kevin P C MinbioleDepartment of Chemistry and Biochemistry, Villanova University, Villanova, Pennsylvania 19085, United States.ORCID 0000-0003-4263-9833
Barry S SelinskyDepartment of Chemistry and Biochemistry, Villanova University, Villanova, Pennsylvania 19085, United States.ORCID 0009-0006-1505-4943
William M WuestDepartment of Chemistry, Emory University, Atlanta, Georgia 30322, United States.ORCID 0000-0002-5198-7744

Funding

Natural Product-Inspired Approaches Toward The Development Of Antivirulence And Species-Specific InhibitorsR35GM119426 · NIGMS · TEMPLE UNIV OF THE COMMONWEALTH · PI William M Wuest · 2016 to 2026
$4.8M
The Development of Novel Disinfectants to Overcome Bacterial ResistanceR15AI185860 · NIAID · VILLANOVA UNIVERSITY · PI MINBIOLE, KEVIN P · 2024 to 2024
$359k
NIAID NIH HHS R15 AI185860NIGMS NIH HHS R35 GM119426
6 · The paper itself

Abstract

Disinfectants represent a crucial tool in killing infectious diseases and play a major role in protecting susceptible communities (hospitals and nursing homes). Inspired by nature, over the past 100 years, scientists have sought to recreate simplified antimicrobial peptides (AMPs) to serve these purposes. Quaternary ammonium compounds (QACs) have been mainstays in the industry, with benzalkonium chloride and didecyldimethylammonium chloride representing everyday disinfection agents. Through exhaustive investigations into alternative QAC structures, we have observed a "floor" in activity, with minimum inhibitory concentration (MIC) values of approximately 0.5 μM and no lower. Interestingly, the same value arises when one calculates the theoretical maximum in activity when considering the mechanism of action, aligning with the previously reported maximum inhibitory efficacy of AMPs. Herein, we encourage that the future development of novel disinfectants instead focus on five specific design elements: cost, time-kill, toxicity, sustainability, and resistance susceptibility.

Indexed as

Anti-Bacterial AgentsDisinfectantsQuaternary Ammonium CompoundsSurface-Active AgentsBenzalkonium CompoundsHumansMicrobial Sensitivity TestsStructure-Activity RelationshipAnti-Bacterial AgentsBenzalkonium CompoundsDisinfectantsQuaternary Ammonium CompoundsSurface-Active Agents

Identifiers

PMID41100167
PMCPMC12621192

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.